Close X
Attorney Spotlight

What colorful method does Claire Miley use to keep up with the latest healthcare regulations as they relate to proposed transactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Securities Law Exchange BlogSecurities Law Exchange blog offers insight on the latest legal and regulatory developments affecting publicly traded companies. It focuses on a wide variety of topics including regulation and reporting updates, public company advisory topics, IPO readiness and exchange updates including IPO announcements, M&A trends and deal news.

Read More >

Attorneys Examine Court Rulings on Refunds of Overpayments Under FCA

ABA's Section of Litigation, Health Law Litigation Article

Publications

February 1, 2016

Bass, Berry & Sims attorneys Anna Grizzle, Brian Roark and Julia Tamulis authored an article for the American Bar Association (ABA) examining two recent rulings that provide direction to healthcare providers related to the timing of refunds of overpayments as defined under Section 6402(d) of the Patient Protection and Affordable Care Act (PPACA). Under the PPACA, a provider has 60 days to refund the overpayment once the discrepancy is identified or risk liability under the False Claims Act (FCA). These cases mark the first time healthcare providers have received any guidance of its repayment obligations required under PPACA. In the article, the authors outline the decision in United States ex rel. Kane v. Healthfirst, Inc. and the settlement in United States ex rel. Odumosu & Mccray v. Pediatric Services of America Healthcare that provide guidance on this issue. 

The full article, "On the Clock: Failure to Timely Refund Overpayments Leads to FCA Exposure," was published by the ABA's Section of Litigation, Health Law Litigation and is available online.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.